Skip to main content

The VIABAHN® Device enables you to deliver high patency and durable outcomes to minimize reinterventions for your patients. 

The cases presented feature a range of challenges that demonstrate the proven performance of the VIABAHN® Device. 

AV graft lesions across the elbow

/Case study

How the VIABAHN® Device changed the natural history of a rapidly failing arteriovenous (AV) access circuit

Submitted by Minneapolis Vascular Physicians

PTA failures of AV graft lesions

/Case study

Treating recurrent PTA failure with the VIABAHN® Device

Submitted by Jason Burgess, M.D.
/Case study

Restoring flow to a brachioaxillary AV graft after multiple failed PTA revisions

Submitted by Nicolas Mouawad, M.D.
/Case study

Restoring durable AV graft flow upon diagnosis of recoil post-PTA

Submitted by Daniel V. Patel, M.D.

Thrombosed AV grafts 

/Case study

Treating a thrombosed AV access graft with the VIABAHN® Device

Submitted by Thomas Ward, M.D.
/Case study

Management of vascular graft stenosis in a patient with recurrent thrombosis

Submitted by Daniel V. Patel, M.D.

Chronic total SFA occlusions 

/Case study

Non-healing ulcer with SFA disease

Submitted by Bruce Gray, M.D.
/Case study

Treating claudication and rest pain due to chronic total occlusion of the SFA

Submitted by James Otto, M.D.

Long SFA lesions 

/Case study

Endovascular treatment of chronic SFA occlusion for limb salvage

Submitted by James Persky, M.D.

In-stent restenosis of the SFA 

/Case study

Diffuse in-stent restenosis in long-stented segment in the SFA

Submitted by Robert Minor, M.D.
/Case study

Reline using the VIABAHN® Device as first line therapy when treating complex in-stent restenosis (ISR)

Submitted by Benjamin J. Pearce, M.D.

*As used by Gore, PROPATEN Bioactive Surface refers to Gore's proprietary CBAS® Heparin Surface. 

Popliteal Artery Aneurysms

/Case study

Treatment of a large popliteal aneurysm

Submitted by Barry Weinstock, MD

IFU Consult instructions

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the market where this product is available. RXOnly 

INDICATIONS FOR USE IN EUROPE: 

The GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface is indicated for the treatment of:

  • de novo or restenotic lesions in the iliac arteries
  • de novo or restenotic lesions in the superficial femoral artery and proximal popliteal artery
  • in-stent restenotic lesions in the superficial femoral artery and proximal popliteal artery
  • stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous (AV) access grafts and in the venous outflow of dialysis access circuits, including the central veins
  • popliteal artery aneurysms and isolated visceral artery aneurysms
  • traumatic or iatrogenic vessel injuries in arteries that are located in the chest cavity, abdominal cavity, or pelvis (except for aorta, coronary, innominate, carotid, vertebral, and pulmonary arteries)  

CONTRAINDICATIONS:

  • Non-compliant lesions where full expansion of an angioplasty balloon catheter was not achieved during pre-dilatation, or where lesions cannot be dilated sufficiently to allow passage of the delivery system.
  • Do not use the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface in patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II. 
Product may not be available in all countries. Please check with your Gore representative for availability